229 related articles for article (PubMed ID: 26468141)
1. Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.
Teich N; Mohl W; Bokemeyer B; Bündgens B; Büning J; Miehlke S; Hüppe D; Maaser C; Klugmann T; Kruis W; Siegmund B; Helwig U; Weismüller J; Drabik A; Stallmach A;
J Crohns Colitis; 2016 Jan; 10(1):61-8. PubMed ID: 26468141
[TBL] [Abstract][Full Text] [Related]
2. Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study.
Wintzell V; Svanström H; Olén O; Melbye M; Ludvigsson JF; Pasternak B
Lancet Child Adolesc Health; 2019 Mar; 3(3):158-165. PubMed ID: 30685366
[TBL] [Abstract][Full Text] [Related]
3. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
5. Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease.
Freitas M; Lima Capela T; Macedo Silva V; Arieira C; Cúrdia Gonçalves T; Dias de Castro F; Moreira MJ; Firmino-Machado J; Cotter J
Pancreas; 2022 Mar; 51(3):288-294. PubMed ID: 35584388
[TBL] [Abstract][Full Text] [Related]
6. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Ledder O; Lemberg DA; Day AS
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
Soh JS; Yun WJ; Kim KJ; Won CH; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Inflamm Bowel Dis; 2015 Apr; 21(4):832-9. PubMed ID: 25789922
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
[TBL] [Abstract][Full Text] [Related]
10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
11. [Azathioprine in inflammatory bowel disease].
Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
Weersma RK; Peters FT; Oostenbrug LE; van den Berg AP; van Haastert M; Ploeg RJ; Posthumus MD; Homan van der Heide JJ; Jansen PL; van Dullemen HM
Aliment Pharmacol Ther; 2004 Oct; 20(8):843-50. PubMed ID: 15479355
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
[TBL] [Abstract][Full Text] [Related]
14. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Montenegro ML; Corral JE; Lukens FJ; Ji B; Kröner PT; Farraye FA; Bi Y
Dig Dis Sci; 2022 Feb; 67(2):423-436. PubMed ID: 33625614
[TBL] [Abstract][Full Text] [Related]
16. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study.
Crepaldi M; Maniero D; Massano A; Pavanato M; Barberio B; Savarino EV; Zingone F
World J Gastroenterol; 2023 Jul; 29(27):4334-4343. PubMed ID: 37545640
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine: state of the art in inflammatory bowel disease.
Sandborn WJ
Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.
Sultan K; Korelitz BI; Present D; Katz S; Sunday S; Shapira I
Inflamm Bowel Dis; 2012 Oct; 18(10):1855-8. PubMed ID: 22241664
[TBL] [Abstract][Full Text] [Related]
20. Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease: Results From a Tertiary Referral Center.
Eskazan T; Bozcan S; Atay K; Yildirim S; Demir N; Celik S; Tuncer M; Hatemi I; Celik AF; Erzin Y
Pancreas; 2021 Oct; 50(9):1274-1280. PubMed ID: 34860811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
